Why Brazil and Australia? Unlocking Opportunities for Diverse and Efficient Clinical Development
As sponsors increasingly seek more diverse patient populations, faster recruitment, and efficient regulatory pathways, Brazil and Australia have emerged as two highly attractive destinations for clinical research.
Both countries offer unique advantages for global clinical development programs. Brazil provides access to a large, diverse population and is undergoing significant regulatory modernization, while Australia combines a streamlined regulatory framework with operational efficiencies that can accelerate study start-up.
Join our webinar to gain practical insights into how these two strategic regions can support your clinical development plans and what you need to know to successfully establish and conduct clinical trials in each market.
Who should attend?
This webinar is designed for clinical operations, regulatory affairs, clinical development, and outsourcing professionals looking to expand or optimize their clinical research activities in Brazil and Australia.
What you will take away
By the end of the session, you will have a clear understanding of:
- The clinical trial opportunities available in Brazil and Australia
- Regulatory requirements and approval pathways
- Expected timelines and cost considerations
- How to leverage patient diversity and local expertise to strengthen your development strategy
- Practical steps to successfully launch and manage clinical trials in both regions